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Abstract
Background: Loss of upper limb function affects up to 85 % of acute stroke patients. Recovery of upper limb
function requires regular intensive practise of specific upper limb tasks. To enhance intensity of practice
interventions are being developed to encourage patients to undertake self-directed exercise practice. Most
interventions do not translate well into everyday activities and stroke patients continue to find it difficult
remembering integration of upper limb movements into daily activities. A wrist-worn device has been developed
that monitors and provides ‘live’ upper limb activity feedback to remind patients to use their stroke arm in daily
activities (The CueS wristband). The aim of this trial is to assess the feasibility of a multi-centre, observer blind, pilot
randomised controlled trial of the CueS wristband in clinical stroke services.
Methods/design: This pilot randomised controlled feasibility trial aims to recruit 60 participants over 15 months
from North East England. Participants will be within 3 months of stroke which has caused new reduced upper limb
function and will still be receiving therapy. Each participant will be randomised to an intervention or control group.
Intervention participants will wear a CueS wristband (between 8 am and 8 pm) providing “live” feedback towards
pre-set movement goals through a simple visual display and vibration prompts whilst undertaking a 4-week upper
limb therapy programme (reviewed twice weekly by an occupational/physiotherapist). Control participants will also
complete the 4-week upper limb therapy programme but will wear a ‘sham’ CueS wristband that monitors upper
limb activity but provides no feedback. Outcomes will determine study feasibility in terms of recruitment, retention,
adverse events, adherence and collection of descriptive clinical and accelerometer motor performance data at
baseline, 4 weeks and 8 weeks.
Discussion: The WAVES study will address an important gap in the evidence base by reporting the feasibility of
undertaking an evaluation of emerging and affordable technology to encourage impaired upper limb activity after
stroke. The study will establish whether the study protocol can be supported by clinical stroke services, thereby
informing the design of a future multi-centre randomised controlled trial of clinical and cost-effectiveness.
Trial registration: ISRCTN:82306027. Registered 12 July 2016.
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Background
Loss of upper limb function affects up to 85 % of acute
stroke patients. Only 5–20 % will regain full function
but 33–60 % will continue to have no function at
6 months [1]. In contrast 80 % of patients are eventually
able to walk again [2]. Stroke patients who are unable to
use their upper limb may experience difficulty being able
to carry out regular activities of daily living leading to a
long-term dependency on families, friends and social
services for support.
Recovery of function is more likely following intensive
and frequent practise of specific activities that are rele-
vant to the patient’s participation in daily life [3]. Theor-
ies of neuroplasticity and motor learning support a
personalised therapy approach based upon frequent re-
hearsal of functionally orientated tasks [4]. Although the
optimal content and amount of therapy to maximize
upper limb recovery for any one individual is unclear
[5, 6], more time spent practising is generally ex-
pected to result in better function with a suggested
dose of at least 20 hours of additional practice over a
4-week period [7]. Providing this level of intensity
under direct supervision is difficult to achieve, with
patients receiving on average just 4–11 minutes of
direct therapy contact time per day [8]. Increasingly,
patients are being encouraged to carry out self-
directed functional upper limb programmes [7]. This
approach aims to enhance rehabilitation without pla-
cing further demands on therapy staff, whilst empow-
ering patients and carers to be more involved in the
recovery process. Large pragmatic studies are still re-
quired to demonstrate whether patients can manage
to independently sustain a therapeutic level of activity
which results in functional benefits.
Technology is being increasingly utilised in stroke re-
habilitation as a means of supporting upper limb re-
habilitation. Qualitative studies indicate that patients
and therapists wish to embrace technology to support
high-intensity upper limb rehabilitation, but barriers in-
clude impractical designs, lack of integration into indi-
vidual therapy programmes and insufficient evidence for
cost-effectiveness [9, 10]. Robot-assisted approaches can
safely achieve high levels of precise repetitions without
direct therapist supervision but the high cost and port-
ability prohibits home therapy [9]. Furthermore these
devices tend to focus on training-specific joint move-
ments which may not translate well into everyday life
[3]. Accelerometers are relatively low-cost small elec-
tronic components commonly found in modern technol-
ogy including mobile phones and video game systems.
Accelerometers measure applied acceleration and can be
used to measure the rate and intensity of body move-
ment in up to three planes (anterior–posterior, mediolat-
eral and vertical) [11]. Rehabilitation research is already
considering the potential therapeutic benefits from ac-
celerometers in video game systems [9] however, pa-
tients may not be able or wish to frequently play video
games and the resulting movements may not promote
motor learning which is directly useful for daily activ-
ities. There is a need to develop affordable technology
which promotes personalised upper limb rehabilitation
activities that can be practised independently by the pa-
tient regardless of whether they are in hospital or at
home.
This study will use a programmable wrist-worn cueing
device incorporating an accelerometer to prompt inde-
pendent practice of functional activity of the upper limb
during rehabilitation after stroke. The device (called the
CueS wristband) incorporates an accelerometer to moni-
tor movement, miniature motor to cause vibration and a
simple Light Emitting Diode (LED) display. The CueS
wristband has been developed by the Open Lab research
group at Newcastle University specifically for people
with upper limb problems after stroke [12]. It sits inside
a soft silicone wristband and, when connected to a port-
able computer, can be programmed with a threshold tar-
get of upper limb movement for the individual wearer
based upon their previous activity record and personal
preferences. The wearer will constantly be guided by a
simple visual representation of coloured LED lights
indicating how close they are to achieving their upper
limb activity goal for the current monitoring interval
(typically blocks of an hour). Should the quantity of
movement over a chosen time interval fall below the
predetermined threshold, the wearer will be prompted
by a gentle vibrating-alert. Through this “live” feedback,
the CueS wristband prompt has the potential to draw at-
tention to the impaired limb when upper limb activity
falls below a personalised activity goal. The purpose of
the prompts will be to encourage the wearer to increase
the amount of impaired upper limb activity throughout
the day, either in response to, or in order to avoid a
prompt. In addition to encouraging an overall in-
crease in movement, when used within a rehabilita-
tion exercise programme the CueS wristband will
remind the wearer to incorporate the motor skills
learnt during therapist-supervised sessions into their
normal daily routines. As well as short-term encour-
agement through personalised prompts and ongoing
visual feedback, an objective report of upper limb ac-
tivity created by the CueS wristband monitoring will
be used to re-confirm the current target threshold to
avoid a prompt and the minimum interval between
prompts, and guide clinical decisions regarding the
frequency of self-directed activity practise.
To develop the CueS wristband we undertook a user-
based design process exploring its acceptability and us-
ability amongst stroke patient volunteers with long-term
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upper limb weakness. They reported that it was acceptable
to receive frequent prompts by vibration, and unblinded
accelerometer data suggested an increase in upper limb
movement following prompts [12]. A prospective evalu-
ation of a 4-week programme using the CueS wristband
within an upper limb therapy programme was then
conducted with eight patients with recent stroke. The
participants experienced an average of four prompts
per day and there was a mean increase in upper limb
activity of 21 % in the hour following a prompt com-
pared to the hour beforehand [13]. These two studies
have facilitated iterative development of the CueS wrist-
band and the experience gained has informed this current
trial protocol.
Study aim
The aim of this trial is to assess the feasibility of a multi-
centre, observer blind, randomised controlled trial
(RCT) of the CueS wristband to prompt independent
practice of functional activity of the upper limb during
rehabilitation after stroke.
Study objectives
1. To determine whether it is possible to enrol one
patient per month from each study centre.
2. To report the attrition of participants in control and
intervention groups.
3. To report participant adherence to wearing the
CueS wristband (defined as the CueS wristband
being worn >80 % of recommended hours).
4. To report the usual rehabilitation care received by
control and intervention groups within the study
intervention period (i.e. frequency of direct therapist
contact).
5. To report the success of outcome assessor blinding
to participant group allocation.
6. To report serious adverse events (SAEs) in control
and intervention groups during the study.
7. To report completeness and summary statistics of
data to inform the design of a future multi-centre
RCT. Data will be recorded at baseline, 4 weeks and
8 weeks:
(a)Stroke impairment and dependency (measured by
the Modified Rankin Scale [14], Barthel Index
[15] and National Institutes of Health Stroke
Scale (NIHSS) [16]).
(b)Upper limb pain (measured by a numerical visual
analogue scale, 0–10)
(c)Overall fatigue (measured by a numerical visual
analogue scale, 0–10)
(d)Upper limb function (measured by the Action
Research Arm Test [17]).
(e)Real world upper limb activity (measured by the
Motor Activity Log [18]).
(f )Upper limb strength (measured by the Motricity
Index [19]).
(g)Unilateral spatial neglect (measured by the Star
Cancellation Test [20]).
8. Objective measurement of affected upper limb
activity (standard wrist worn accelerometer worn for
3 days after the 4- and 8-week outcome visits).
Methods/design
Study design
This study is a pragmatic, parallel, observer blind,
pilot RCT. A summary of the overall study design is
presented in Fig. 1. The study strategy is registered,
constructed and presented according to the recom-
mendations for Interventional Trials (SPIRIT) [21]
(SPIRIT checklist, Additional file 1).
Study setting
Trial activity will take place in NHS stroke services in
North East England who provide in-patient and community
therapy follow-up services. Study sites are listed on the
National Institute for Health Research UK Clinical Trials
Gateway (https://www.ukctg.nihr.ac.uk/home/). Potential
participants will be identified and recruited from stroke
units and community stroke services. The intervention will
be delivered by occupational therapists and physiotherapists
on the stroke unit, in the community or both combined de-
pending upon when participants are recruited and the stage
they are at in their rehabilitation.
Study population
Adults with any stroke subtype who fulfil the following
criteria will be eligible:
Inclusion criteria
 Age ≥ 18 years.
 Over 48 hours but less than 3 months post stroke onset.
 New reduced upper limb function on one side.
 Able to provide informed consent to participate in
the study.
 Living within the community services catchment
area of a participating study centre.
 Receiving at least twice weekly NHS therapy review
which is planned to continue for 4 weeks from the
start of the intervention period.
Exclusion criteria
 Severely reduced upper limb function which results
in inability to lift the affected hand off the lap when
sitting.
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 Unable to follow the programme due to significant
cognitive impairment or communication difficulties.
 Other significant upper limb impairment e.g. fixed
contracture, frozen shoulder, severe arthritis, upper
limb pain that inhibits participation in the
programme.
 Diagnosis likely to interfere with rehabilitation e.g.
registered blind, severe visual problems as a result
of stroke, palliative treatment approach being
provided.
 Unable to sense both CueS wristband vibratory
prompts and visual display.
Sample size
A formal sample size calculation has not been under-
taken as this is a pilot study. Based upon recruitment
rates in previous trials [22, 23] we predict that 60 pa-
tients can be enrolled in 15 months at a rate of one pa-
tient per study centre, per month.
Case ascertainment, recruitment and consent
Potentially eligible participants will be identified and
provided with study details by health care professionals
and National Institute for Health Research Clinical
Research Network research support staff working within
Fig. 1 Study flow diagram
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each stroke service. Written consent will be obtained by
research support staff after allowing sufficient time for
study information to be considered.
Recruitment activity at each site will be monitored
prospectively against the target. Only simple strategies
for achieving adequate participant enrolment will put in
place (e.g. training sessions for new staff ) as this is a
feasibility study with one objective being to determine
whether one participant per site per month can be
recruited.
Baseline assessment
A baseline assessment will be performed by the re-
search support staff following patient consent to study
participation. The following data will be collected:
date of stroke, first ever or recurrent stroke, stroke type
(e.g. infarct, haemorrhage), hand dominance, National
Institutes of Health Stroke Scale (NIHSS) [16], pre and
post-stroke Barthel score [15], upper limb pain and overall
fatigue (measured by a numerical visual analogue
scale, 0–10); upper limb function (measured by the
Action Research Arm Test) [17]; real world upper limb ac-
tivity (measured by the Motor Activity Log [18]); upper
limb strength (measured by the Motricity Index) [19]
and unilateral spatial neglect (measured by the Star
Cancellation Test [20]).
Randomisation
Individual participants will be randomised by a computer-
generated sequence accessed via a central telephone ser-
vice hosted at Newcastle University Stroke Research
Group. Participants will be stratified according to study
centre and randomised to intervention and control groups
in a 1:1 ratio. The randomisation telephone call will be
conducted by a member of the clinical team in order to
conceal group allocation from the local research support
staff who will be performing the outcome assessments.
Study interventions
Study intervention group
The intervention group will receive a CueS wristband (full
description below) and a personalised upper limb therapy
programme (described below). The CueS wristband will
provide ‘live’ feedback and objective reports to review dur-
ing therapy review sessions on upper limb activity under-
taken during the 4-week self-directed personalised upper
limb therapy programme. Intervention participants will be
encouraged to respond to feedback from the CueS wrist-
band by undertaking different goal-directed activities
identified in their upper limb therapy programme.
CueS wristband
The CueS wristband comprises two CE marked compo-
nents which are manufactured by Axivity (Newcastle
upon Tyne, UK): the WAX9 Inertial Measurement Unit
(movement sensor) and the soft silicone wristband
which allows it to be worn comfortably. There is a
standard micro-USB socket for data download, program-
ming and charging. A portable computer can download
and display the stored activity and prompt data from any
date and time point.
The CueS wristband supplied to intervention patients
will constantly record impaired upper limb movement
and provide feedback through three mechanisms:
1. A gentle vibration when arm movement over a
selected time unit (default: 1 hour) is below a
threshold which has been pre-set using the wearer’s
previously recorded movement data (default: mean
plus 5 %). This “live” feedback is to encourage
general activity towards the upper end of the
individual’s current ability. The level can be adjusted
during the twice weekly therapy review to be more or
less challenging according to patient preference.
2. A visual LED display of current arm movement
activity in relation to the pre-set threshold. This is
to give patients real time feedback on the degree of
arm movement during the current prompt interval
and how close they are to their pre-determined
threshold target for that time of day.
3. A pictorial display of CueS data on a portable
computer to represent daily arm activity and the
timing of prompts. This is to provide the therapist
and patient with information during the twice
weekly review, which will assist with setting the
prompt threshold and selecting activities to include
in the therapy programme.
Before randomisation, the patients’ clinical NHS occu-
pational/physiotherapist will confirm that the patient
will be able to feel the CueS vibratory prompt and/or see
the LED display. For the first 3 days of the 4-week
programme, the CueS wristband will only monitor af-
fected upper limb movement and no prompts will be de-
livered. At the patient’s first review for the study their
NHS therapist will use the data collected from the previ-
ous 3 days to agree initial baseline prompt settings with
the patient and discuss how frequently prompts should
be delivered. The maximum frequency for receiving a
prompt (i.e. minimum time allowed between prompts)
will be set at a default of 60 minutes but can be adjusted
from 30 minutes to 4 hours. The default prompt thresh-
old will be the mean activity value or “signal vector
magnitude” from across the first 3 days plus 5 %, i.e. a
prompt will be delivered if the sum of arm movement
activity falls below this target threshold throughout the
minimum pre-set interval allowed between prompts.
The NHS therapist will review the therapy programme
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and CueS data report twice weekly. If prompts were trig-
gered since the last visit, they will discuss continuing
with the same or a lower threshold and review possible
arm activity responses. If no prompts were triggered
they will discuss selection of a more challenging moni-
toring level by increasing the threshold to the mean plus
10 % or mean plus 20 %. If too many prompts were re-
ceived they will lengthen the prompt frequency interval
according to the number of prompts per day which is
acceptable to each patient. The aim is to encourage arm
activity which is in the upper half of the patient’s indi-
vidual range of ability without triggering inconvenient
prompts or precipitate desensitization to prompts. At
each review session the therapist will complete a therapy
review form to capture safety reporting, times when the
CueS wristband was not worn, prompt information and
any adjustment to prompt threshold settings.
Upper limb therapy programme
The upper limb therapy programme will be delivered by
the patients’ NHS physiotherapist or occupational therapist.
The programme will last for 28 days in total, which has
been selected as a pragmatic interval to achieve >20 hours
of upper limb activity practice in line with findings of a
recent Cochrane review [24]. The programme has been
designed to support and work with normal NHS upper
limb therapy programmes. The aim is to increase the use of
the affected upper limb and integrate upper limb activities
undertaken in therapy into normal daily routines.
At the initial therapy session, each participant will be
provided with a participant handbook which will contain
their individualised upper limb therapy programme as it
progresses over the 4-week period. The therapists will
support the participant to identify a range of goal-
directed upper limb activities which reflect part or whole
movements needed to undertake a specific activity e.g.
reaching to pick up a glass. These activities will be re-
corded by participants or their relatives on a daily activ-
ities log in their participant handbook. The daily
activities log will remind participants of activities to
practise. The continuing relevance of activities will be
reviewed and progressed over the 4 weeks at twice
weekly face-to-face occupational therapy or physiotherapy
review sessions (i.e. every 3–4 days). It will be left up to
the participants to decide how often and when they wish
to practice, but all will be informed that additional prac-
tice up to an hour every day may improve recovery.
Any usual clinical treatment will continue. In addition,
participants will be requested to record whether they
have received any upper limb therapy during usual care
therapy on their daily activities log sheet. Usual care
upper limb therapy is face-to-face therapy provided by
an occupational therapist, physiotherapist or therapy
assistant.
Study control group
The control group will receive a sham CueS wristband
and a personalised upper limb therapy programme
Sham CueS wristband
Patients allocated to the control group will wear a ‘sham’
CueS wristband which will monitor activity levels of the
impaired limb but not provide any feedback via prompts,
visual LED display or pictorial display. All alert functions
will be deactivated and activity data will not be viewable
by the clinical therapist. Therapists will visit patients
twice weekly to review the choice of practice activities in
the same manner as the intervention group in order to
promote attention matching (see the upper limb therapy
programme).
Upper limb therapy programme
Control participants will receive the same personalised
upper limb therapy programme as the intervention
group (see description above).
Training
All occupational and physiotherapists delivering the
WAVES programme will have received half a day train-
ing about the study protocol, delivery of the upper limb
therapy programme and reviewing the CueS wristband
data. Therapists will also receive a manual and a phone
number for advice from the study co-ordinating team at
Newcastle University. Research support staff will receive
a half day training on the study protocol, outcome mea-
sures and recording study data. A signed log will be kept
of training undertaken.
Outcome assessments
Outcomes will be assessed at 4 weeks (+/− 3 days) and
8 weeks (+/− 5 days) following day 1 of the therapy
programme. Assessments will be undertaken by research
support staff who have not been informed of participant
group allocation.
The following data will also be collected: stroke de-
pendency (measured by the Modified Rankin Scale [14],
Barthel Activities of Daily Living Index [15]); pain and
fatigue (measured by a numerical visual analogue scale,
0–10); upper limb function (measured by the Action
Research Arm Test [17]); real world upper limb activity
(measured by the Motor Activity Log [18]); arm strength
(measured by the Motricity Index [19]); and unilateral
spatial neglect (measured by the Star Cancellation Test
[20]).
Participants will be provided with a standard wrist-
worn accelerometer during the week 4 and week 8 as-
sessments, which is to gather upper limb activity out-
come data for the next 3 days. They will then send it
back to research support staff in the envelope provided.
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Blinding
It is intended that both patients and outcome asses-
sors are blinded to treatment group. Group allocation
concealment will be maintained by using a centralised
web-based randomisation service. Outcome assess-
ments will be performed by local research support
staff who will be blinded to treatment allocation.
After each assessment, the researcher will be asked to
record whether they have unintentionally become
aware of treatment allocation. Success of outcome
assessment blinding will be reported. Therapists
delivering the intervention will be instructed not to
inform patients if they are in the ‘intervention’ or the
‘control’ group. Participants will all be given a general
patient information sheet prior to randomisation
which does not describe differences in CueS wrist-
band function between the intervention and control
groups. After randomisation participants will receive a
group-specific patient information sheet with more
details about what to expect from their CueS wrist-
band. This is to reduce control group expectations
that prompts could occur.
Study withdrawal
No specific study withdrawal criteria have been set. Par-
ticipants may stop the therapy programme or withdraw
altogether from the study at any time without giving a
reason. Should a patient decide to stop the therapy
programme, the data already collected will be used in
the analysis unless consent is specifically withdrawn and
their permission will be sought to continue with the out-
come assessments.
Recording and reporting of adverse events
All adverse events will be recorded for the duration of
each participant’s involvement in the study but only ser-
ious adverse events (SAEs) will be specifically reported.
Recording will take place at the outcome assessments by
inclusion of the following question: “Are there any new
medical problems since the last study assessment?” We
will specifically enquire about the presence of pain in
the affected upper limb and overall fatigue. Events con-
sidered to be SAEs will subsequently be documented
onto a separate study SAE form, including a report of
causality and expectedness.
Data management
Data will be recorded locally on study-specific docu-
ments and transferred to the coordinating centre via
an industry-standard secure online database, using a
pseudo-anonymised study identification code to link
individual participants with their local health records.
All paper copies of study documents will be retained
at local sites and stored securely for 5 years in line
with sponsor policy. The online database is encrypted
and only accessible via individual passwords and
meets current industry Good Clinical Practice stan-
dards. It has been certified by the Lloyd’s Register
Quality Assurance according to the international in-
formation security norm ISO 27001:2013 and provides
its services in accordance with the NEN7510 norm for in-
formation security in healthcare (https://castoredc.com/
security-statement/).
Data monitoring
Interim safety and efficacy data will not be formally
reviewed against pre-determined criteria for stopping
early as this study is a feasibility pilot. A formal data
monitoring committee or equivalent body will not be
convened, but safety data will be prospectively reviewed
at monthly project management meetings with the chief
investigator. The well-being of individual participants
will be closely monitored by clinicians as they will still
be patients within a local clinical service.
Auditing
As this is a feasibility study, regular site visits for audit
and monitoring will not be carried out.
Data analysis
As this is a feasibility study, there will be no comparative
statistics reported for outcomes. Data will be presented
as summary descriptive statistics i.e. median and IQR,
plus change from baseline measurement as appropriate.
Data will be used to inform the sample size calculation
for a future clinical efficacy study.
To describe trial feasibility we will report recruitment,
attrition and adherence to the CueS therapy programme
by participants. Usual stroke rehabilitation therapist con-
tacts will be counted. Success of outcome assessment
blinding and adverse events will be described.
Access to data
Data will be accessed and analysed by the study team
and chief investigator at Newcastle University. Anon-
ymised CueS data will be analysed by members of the
study team who specialise in activity data processing and
are employed by Open Lab, School of Computing
Science at Newcastle University, England.
Protocol amendments
Any amendments will be notified to the regional ethics
committee. Once amendments have been cleared by the
regional ethics committee, amendments will be will be
communicated from the study team directly to local re-
search support and therapy teams via email and tele-
phone communication, as well as through the local
organisation Research and Development Office.
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Confidentiality
Personal data will be regarded as strictly confidential.
The study will comply with the Data Protection Act, 1998
and Caldicott Principles. All study records will be kept at
the research centre and/or Newcastle University with re-
stricted access. All trial documentation will be retained for
future audit and inspection for 5 years in line with the
sponsor policies. Participants will not be identified in any
report or publication arising from this research.
Study sponsor
The study sponsor is Northumbria Healthcare NHS
Trust. The contact for the study sponsor is: Ms Caroline
Potts, Head of Research and Development, Research and
Development Department, Northumbria Healthcare
NHS Trust, North Tyneside General Hospital, Rake
Lane, North Shields, NE29 8NH, UK, Tel: +44844 811
8111 extension 2842 Email: caroline.potts@northumbria-
healthcare.nhs.uk. The study sponsor and funders have no
role in study design; collection; management; analysis;
interpretation of data; write up and reporting.
Dissemination of results
The data will be the property of Northumbria Healthcare
NHS Foundation Trust and Newcastle University. Publi-
cation will be the responsibility of the chief investigator.
Results will be presented at national and international
conferences, and reported in peer-reviewed journals. Re-
ports will be written for the study sponsor and regulatory
bodies. A summary of the results will be sent to study par-
ticipants. Local authorship eligibility guidelines will be
followed. We do not intend to use professional writers.
Discussion
Frequent practice of functionally orientated upper limb
movements has the potential to improve recovery after
stroke [24]. Current evidence-based approaches rely
upon an increase in direct contact therapy time, which
can lead to prohibitively high costs [25]. Low-cost tech-
nology, promoting self-directed upper limb therapy, of-
fers an affordable and potentially effective solution,
which might encourage use of the impaired limb during
the wearer’s daily routine. The CueS wristband is a
programmable activity feedback device that has been co-
designed with and for people with stroke with upper
limb impairment. This type of “live” feedback technology
has not been previously used during stroke rehabilitation
and has the potential to promote an increase in upper
limb use and therapy practise, facilitating independence
and opportunities to maximise plasticity [26].
Strengths
A key strength of the intervention we are testing is de-
velopment by a multi-disciplinary team with direct
patient engagement. The team consists of experts in
interaction design, ubiquitous computing and clinical
stroke research. The CueS wristband functions have
been developed iteratively based upon patient feedback
and it is now ready for a pilot stage of clinical testing
under trial conditions, to determine whether a large
study of clinical efficacy is possible. A key difficulty in
rehabilitation research is the blinding of participants and
clinical staff to group allocation. To reduce the possibil-
ity that control participants might behave differently
they will wear a sham CueS wristband and be enrolled
through a two-stage information process which will not
lead to expectations that prompts could occur. The out-
come assessments (clinical and activity data) will be per-
formed by research staff who will not be informed of
individual participant group allocations. Finally, unlike
previous upper limb rehabilitation trials in stroke with a
restrictive range of upper limb impairment, our inclu-
sion criteria for are wide, increasing external validity.
Limitations
A limitation of the trial is that all sites are based in
North East England due to the pilot nature of the study,
thereby potentially limiting generalizability. We are
selecting patients who are less than 3 months after
stroke because they are still in regular contact with
therapists to support the clinical aspects of the study,
which limits the applicability of trial findings to those
who have been living with stroke-related upper limb
impairment for longer. If the device is acceptable and
feasible under these conditions, additional studies will
need to consider whether patients require regular
therapy contact or could even use the device without
any clinician support.
We have presented the protocol for a multi-centre
feasibility trial of a novel method for providing persona-
lised “live” feedback about upper limb activity during
stroke rehabilitation, which aims to increase general
upper limb functional activity with a minimal resource
increment. The CueS wristband is affordable novel tech-
nology which could potentially be delivered within
current rehabilitation services. If this small trial shows it
is a feasible approach, further studies will be required to
demonstrate clinical efficacy, the impact upon quality of
life post stroke and cost-effectiveness for different pa-
tient groups.
Trial status
This manuscript has been prepared using protocol V1
dated 26 January 2016. At the time of this publication
four sites are taking part and three patients have been
enrolled. Enrolment of participants will be completed by
August 2017. Results will be submitted for publication
in January 2018.
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